Androgenic alopecia
Conditions
Interventions
This is a two-arm, double-blind, randomized controlled clinical study. 100 female patients will be admitted, randomized (1:1) into 2 groups: 50 women will receive oral minoxidil 1 mg per day (Minoxidi
Sponsors
Hospital Moriah - Rede Moriah Saúde LTDA
Hospital Moriah - Rede Moriah Saúde LTDA
Eligibility
Sex/Gender
Female
Age
18 Years to 55 Years
Inclusion criteria
Inclusion criteria: Female; Age between 18 and 55 years old; diagnosis of Female pattern hair loss classified on the Sinclair scale from III to IV
Exclusion criteria
Exclusion criteria: Previous treatment for hair loss in the last 6 months; hypertension; heart disease; nephropathy; other causes of hair loss or scalp dermatoses; adverse effects to treatments that prevent them from continuing the study ; Participant deprived of liberty by court or administrative decision, residing in a social or health care institution, under legal protection, without the capacity to express consent or comply with the requirements of the protocol ; Withdrawal of consent by the participant; Protocol violations or deviation
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Evaluate the variation in the density of terminal wires in the target area between the 1th and 24th week ;The use of sublingual minoxidil as a treatment for APF is expected to provide similar or superior results to oral minoxidil and with fewer side effects | — |
Secondary
| Measure | Time frame |
|---|---|
| The use of sublingual minoxidil as a treatment for APF is expected to provide similar or superior results to oral minoxidil and with fewer side effects;Evaluate and compare standardized clinical photograph assessment by dermatologists ;Evaluate the variation in the density of total hairs in the target area | — |
Countries
Brazil
Contacts
Public ContactAlice Cortes
Clínica Marina Barletta
Outcome results
None listed